Target intelligence / Profile preview

Immunoglobulin heavy variable 3-25 (IGHV3-25)

Target
IGHV3-25
Molecular classification
Immunoglobulin gene segment, Immunoglobulin superfamily (IgSF), Antibody variable region gene
01

Overview

Immunoglobulin heavy variable 3-25 is a gene segment located within the human immunoglobulin heavy chain locus, encoding part of the variable region of antibody heavy chains. This segment is one of many IGHV segments, contributing through recombination (with D and J segments) and hypermutation to the specificity and diversity of antibodies produced by B-lymphocytes. The variable region it encodes forms, together with the light chain variable region, the antigen-binding site of immunoglobulin molecules[1][2][5]. IGHV3-25 is mainly referenced in studies of antibody gene use, repertoire diversity, and immune response rather than as a direct drug or therapeutic target. If you are seeking information about a therapeutic antibody, those are the proteins encoded by assembled IGHV (including IGHV3-25) segments, not the gene segment itself. IGHV3-25 is not the name of an antibody, but the gene segment used in antibody construction.

Other names
3-25PIGHV325IGHV3-25
02

Biological functions

Antigen recognition (as part of the antibody variable region)Immune responseGeneration of antibody diversity (via V(D)J recombination and somatic hypermutation)
03

Disease associations

Other (variable region gene segments can indirectly be implicated in infection, autoimmunity, cancer, or antibody-related diseases, but IGHV3-25 itself is not a direct pathogenetic factor)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-25 (IGHV3-25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-25 (IGHV3-25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call